Instituto Português de Oncologia Francisco Gentil, Centro Regional de Oncologia de Coimbra, EPE

Coimbra 3000-075

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, Carcinoma, Hepatocellular, FGFR2 Gene Mutation, Ovarian Cancer

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma — Completed
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early